Thiogenesis Therapeutics, Corp. Company Information
Thiogenesis Therapeutics, Corp.'s employee growth, exchange listings and data sources
Key Information
- Name: Thiogenesis Therapeutics, Corp.
- Ticker: TTI
- Exchange: TSXV
- Founded: NaN
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: CA$30.482m
- Shares Outstanding: 45.50m
- Website: https://www.thiogenesis.com
Location
- Thiogenesis Therapeutics, Corp.
- 4 King Street West
- Suite 401
- Toronto
- Ontario
- M5H 1B6
- Canada
Listings
Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
---|---|---|---|---|---|---|
TTI | TSXV (TSX Venture Exchange) | Yes | Common Shares | CA | CAD | Apr 2022 |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/11/20 18:22 |
End of Day Share Price | 2024/11/19 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.